- Potential benefitMay increase public awareness, potentially improving symptom recognition and earlier care-seeking.
- Potential benefitMay boost donations and fundraising for brain tumor research and support services.
- WorkersEncourages researcher and nonprofit collaboration, possibly facilitating new partnerships or trials.
Expressing support for the designation of May 2026 as "National Brain Tumor Awareness Month".
Referred to the House Committee on Energy and Commerce.
This resolution expresses the House of Representatives support for designating May 2026 as National Brain Tumor Awareness Month and encourages awareness, research collaboration, and support for patients and caregivers. It is a simple resolution adopted by the House alone and does not create a law, spend money, or direct federal agencies to act. In practice it is a formal, non-binding statement of the House's position and intent.
This non-binding House resolution expresses support for designating May 2026 as “National Brain Tumor Awareness Month.” It encourages increased public awareness, honors people affected by brain tumors, supports development of better treatments, and urges collaborative research.
The resolution does not authorize spending or create new federal programs.
H.Res is a non‑binding House resolution and does not create law; content is uncontroversial but cannot become statute as written.
Relative to its intended legislative type, this bill is a straightforward commemorative resolution that clearly states the problem and purpose and uses standard, intentionally general nonbinding language to encourage awareness and collaboration without creating obligations or funding commitments.
Progressives emphasize use to push research funding and equity
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Potential burdenThe resolution is purely symbolic and does not provide new research funding or mandates.
- Potential burdenLikely has limited measurable effect on brain tumor mortality or long-term treatment outcomes alone.
- Potential burdenMay duplicate existing awareness campaigns without adding coordination or resources.
Why the argument around this bill splits.
Progressives emphasize use to push research funding and equity
Strongly supportive of the designation as a way to spotlight unmet medical needs and health inequities.
Sees the resolution as an opportunity to galvanize research funding, patient supports, and attention to underserved communities, though notes it is symbolic.
Generally supportive; views the resolution as a low-cost, bipartisan recognition that raises awareness.
Appreciates honoring sufferers and encouraging research while noting the lack of binding commitments or budgetary impacts.
Likely supportive of the awareness designation but cautious about expanding federal roles.
Views the resolution as acceptable symbolic recognition, preferring private-sector and nonprofit leadership on research funding and services.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
H.Res is a non‑binding House resolution and does not create law; content is uncontroversial but cannot become statute as written.
- Whether committee will schedule it for floor consideration
- Floor calendar congestion and procedural priorities
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Progressives emphasize use to push research funding and equity
H.Res is a non‑binding House resolution and does not create law; content is uncontroversial but cannot become statute as written.
Relative to its intended legislative type, this bill is a straightforward commemorative resolution that clearly states the problem and purpose and uses standard, intentionally general nonbinding language to encourage aw…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.